In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Efficacy of Endoscopic Third Ventriculostomy (ETV) After Shunt Malfunction in the Pediatric Age Group: A Meta-analysis to Evaluate the Impact of Hydrocephalus Aetiology

    Final Number:
    213

    Authors:
    Mueez Waqar MBChB, MRes; Jonathan Ellenbogen FRCS; Conor Mallucci

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: ETV is increasingly used in place of shunt revision for shunt malfunction (secondary ETV). In this meta-analysis, we sought to explore the impact of hydrocephalus aetiology on outcome of secondary versus primary ETV in the pediatric age group.

    Methods: Systematic and independent MEDLINE searches by two authors. Inclusion criteria: (1) studies including a predominance of children and adolescents (=18); (2) description of clinical outcomes after secondary ETV. ETV success was defined as the lack of need for a shunt.

    Results: Fifteen studies were included. 519 patients underwent a secondary ETV for shunt malfunction (85%) or infection (15%). The mean age was 9.8 years (95% CI 7.9-11.8 years). Aetiology of hydrocephalus was: chiari malformation (31.5%), aqueductal stenosis (29.3%), intraventricular haemorrhage (17.7%), meningitis (13.1%) and tumours (8.4%). The overall ETV success rate was 70.5% over a median follow-up period of 45.5 months (range 1-190 months). For acqueductal stenosis and tumours, there was no significant difference in success rate between primary and secondary ETV (OR = 1.19, 95% CI 0.46-3.11; p = 0.74). Secondary ETV had a significantly higher success rate than primary ETV in patients with hydrocephalus due to chiari malformation (OR = 5.57, 95% CI 2.81-11.00; p < 0.001) and haemorrhage or infection (OR = 5.79, 95% CI 2.46-13.61; p < 0.001).

    Conclusions: The efficacy of secondary ETV varies depending on hydrocephalus aetiology. Secondary ETV may be more efficacious than primary ETV in certain disease states due to a state of acquired acqueductal stenosis with chronic CSF diversion.

    Patient Care: This meta-analysis will stimulate discussion and could act as a foundation for prospective studies looking at secondary ETV.

    Learning Objectives: By the conclusion of this session, participants should be able to: - Appreciate the heterogeneity of published studies relating to ETV performed after shunt malfunction - Appreciate the differences in outcome between secondary versus primary ETV

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy